These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 1694729)

  • 1. Preferential peptide specificity and HLA restriction of myelin basic protein-specific T cell clones derived from MS patients.
    Zhang JW; Chou CH; Hashim G; Medaer R; Raus JC
    Cell Immunol; 1990 Aug; 129(1):189-98. PubMed ID: 1694729
    [TBL] [Abstract][Full Text] [Related]  

  • 2. T lymphocyte lines and clones selected against synthetic myelin basic protein 82-102 peptide from Japanese multiple sclerosis patients.
    Inobe J; Yamamura T; Kunishita T; Tabira T
    J Neuroimmunol; 1993 Jul; 46(1-2):83-90. PubMed ID: 7689597
    [TBL] [Abstract][Full Text] [Related]  

  • 3. T cell response to myelin basic protein in the context of the multiple sclerosis-associated HLA-DR15 haplotype: peptide binding, immunodominance and effector functions of T cells.
    Vergelli M; Kalbus M; Rojo SC; Hemmer B; Kalbacher H; Tranquill L; Beck H; McFarland HF; De Mars R; Long EO; Martin R
    J Neuroimmunol; 1997 Aug; 77(2):195-203. PubMed ID: 9258250
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fine specificity and HLA restriction of myelin basic protein-specific cytotoxic T cell lines from multiple sclerosis patients and healthy individuals.
    Martin R; Jaraquemada D; Flerlage M; Richert J; Whitaker J; Long EO; McFarlin DE; McFarland HF
    J Immunol; 1990 Jul; 145(2):540-8. PubMed ID: 1694881
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differences between T-cell reactivities to major myelin protein-derived peptides in opticospinal and conventional forms of multiple sclerosis and healthy controls.
    Minohara M; Ochi H; Matsushita S; Irie A; Nishimura Y; Kira J
    Tissue Antigens; 2001 May; 57(5):447-56. PubMed ID: 11556969
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Myelin basic protein-specific T lymphocyte lines from MS patients and healthy individuals.
    Pette M; Fujita K; Kitze B; Whitaker JN; Albert E; Kappos L; Wekerle H
    Neurology; 1990 Nov; 40(11):1770-6. PubMed ID: 1700336
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Myelin basic protein-specific T lymphocyte repertoire in multiple sclerosis. Complexity of the response and dominance of nested epitopes due to recruitment of multiple T cell clones.
    Meinl E; Weber F; Drexler K; Morelle C; Ott M; Saruhan-Direskeneli G; Goebels N; Ertl B; Jechart G; Giegerich G
    J Clin Invest; 1993 Dec; 92(6):2633-43. PubMed ID: 7504690
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human myelin basic protein-specific cytolytic T lymphocyte clones are functionally restricted by HLA class II gene products.
    Weber WE; Vandermeeren MM; Raus JC; Buurman WA
    Cell Immunol; 1989 Apr; 120(1):145-53. PubMed ID: 2467752
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A review of T-cell receptors in multiple sclerosis: clonal expansion and persistence of human T-cells specific for an immunodominant myelin basic protein peptide.
    Wucherpfennig KW; Hafler DA
    Ann N Y Acad Sci; 1995 Jul; 756():241-58. PubMed ID: 7544075
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cytokine phenotype of human autoreactive T cell clones specific for the immunodominant myelin basic protein peptide (83-99).
    Hemmer B; Vergelli M; Calabresi P; Huang T; McFarland HF; Martin R
    J Neurosci Res; 1996 Sep; 45(6):852-62. PubMed ID: 8892097
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunodominance of a low-affinity major histocompatibility complex-binding myelin basic protein epitope (residues 111-129) in HLA-DR4 (B1*0401) subjects is associated with a restricted T cell receptor repertoire.
    Muraro PA; Vergelli M; Kalbus M; Banks DE; Nagle JW; Tranquill LR; Nepom GT; Biddison WE; McFarland HF; Martin R
    J Clin Invest; 1997 Jul; 100(2):339-49. PubMed ID: 9218510
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Restricted TCR Valpha gene rearrangements in T cells recognizing an immunodominant peptide of myelin basic protein in DR2 patients with multiple sclerosis.
    Zang YC; Kozovska M; Aebischer I; Li S; Boehme S; Crowe P; Rivera VM; Zhang JZ
    Int Immunol; 1998 Jul; 10(7):991-8. PubMed ID: 9701037
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A study of human T-cell lines generated from multiple sclerosis patients and controls by stimulation with peptides of myelin basic protein.
    Pender MP; Csurhes PA; Houghten RA; McCombe PA; Good MF
    J Neuroimmunol; 1996 Oct; 70(1):65-74. PubMed ID: 8862136
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Visualization of myelin basic protein (MBP) T cell epitopes in multiple sclerosis lesions using a monoclonal antibody specific for the human histocompatibility leukocyte antigen (HLA)-DR2-MBP 85-99 complex.
    Krogsgaard M; Wucherpfennig KW; Cannella B; Hansen BE; Svejgaard A; Pyrdol J; Ditzel H; Raine C; Engberg J; Fugger L
    J Exp Med; 2000 Apr; 191(8):1395-412. PubMed ID: 10770805
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MHC-restriction, cytokine profile, and immunoregulatory effects of human T cells specific for TCR V beta CDR2 peptides: comparison with myelin basic protein-specific T cells.
    Chou YK; Weinberg AD; Buenafe A; Bourdette DN; Whitham R; Kaleeba JA; Robey IF; Kavanagh DG; Offner H; Vandenbark AA
    J Neurosci Res; 1996 Sep; 45(6):838-51. PubMed ID: 8892096
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human anti-idiotypic T cells induced by TCR peptides corresponding to a common CDR3 sequence motif in myelin basic protein-reactive T cells.
    Zang YC; Hong J; Rivera VM; Killian J; Zhang JZ
    Int Immunol; 2003 Sep; 15(9):1073-80. PubMed ID: 12917259
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structural requirements for binding of an immunodominant myelin basic protein peptide to DR2 isotypes and for its recognition by human T cell clones.
    Wucherpfennig KW; Sette A; Southwood S; Oseroff C; Matsui M; Strominger JL; Hafler DA
    J Exp Med; 1994 Jan; 179(1):279-90. PubMed ID: 7505801
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Individual specific bias usage of HLA-DR antigens in the restriction of myelin basic protein-reactive T cell clones.
    Rohowsky-Kochan C; Eiman D; Cook SD
    J Neurol Sci; 1993 Jul; 117(1-2):120-9. PubMed ID: 7691992
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recognition of the immunodominant myelin basic protein peptide by autoantibodies and HLA-DR2-restricted T cell clones from multiple sclerosis patients. Identity of key contact residues in the B-cell and T-cell epitopes.
    Wucherpfennig KW; Catz I; Hausmann S; Strominger JL; Steinman L; Warren KG
    J Clin Invest; 1997 Sep; 100(5):1114-22. PubMed ID: 9276728
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structure of human T-cell receptors specific for an immunodominant myelin basic protein peptide: positioning of T-cell receptors on HLA-DR2/peptide complexes.
    Wucherpfennig KW; Hafler DA; Strominger JL
    Proc Natl Acad Sci U S A; 1995 Sep; 92(19):8896-900. PubMed ID: 7568039
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.